IE50231B1 - Salts of(+)-catechin,their preparation and use,and compositions and formulations containing them - Google Patents

Salts of(+)-catechin,their preparation and use,and compositions and formulations containing them

Info

Publication number
IE50231B1
IE50231B1 IE1823/80A IE182380A IE50231B1 IE 50231 B1 IE50231 B1 IE 50231B1 IE 1823/80 A IE1823/80 A IE 1823/80A IE 182380 A IE182380 A IE 182380A IE 50231 B1 IE50231 B1 IE 50231B1
Authority
IE
Ireland
Prior art keywords
acid
salt
catechin
basic amino
hydrosoluble
Prior art date
Application number
IE1823/80A
Other languages
English (en)
Other versions
IE801823L (en
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of IE801823L publication Critical patent/IE801823L/xx
Publication of IE50231B1 publication Critical patent/IE50231B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
IE1823/80A 1979-08-30 1980-08-29 Salts of(+)-catechin,their preparation and use,and compositions and formulations containing them IE50231B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/071,076 US4285964A (en) 1979-08-30 1979-08-30 Salts of (+)-catechine, their preparation and use, and compositions containing these salts

Publications (2)

Publication Number Publication Date
IE801823L IE801823L (en) 1981-02-28
IE50231B1 true IE50231B1 (en) 1986-03-05

Family

ID=22099096

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1823/80A IE50231B1 (en) 1979-08-30 1980-08-29 Salts of(+)-catechin,their preparation and use,and compositions and formulations containing them

Country Status (18)

Country Link
US (1) US4285964A (cg-RX-API-DMAC10.html)
JP (2) JPS5923313B2 (cg-RX-API-DMAC10.html)
AT (1) AT372381B (cg-RX-API-DMAC10.html)
BE (1) BE884743A (cg-RX-API-DMAC10.html)
CA (1) CA1172259A (cg-RX-API-DMAC10.html)
CH (1) CH646412A5 (cg-RX-API-DMAC10.html)
DE (1) DE3031710C2 (cg-RX-API-DMAC10.html)
DK (1) DK153948C (cg-RX-API-DMAC10.html)
ES (1) ES8106513A1 (cg-RX-API-DMAC10.html)
FI (1) FI72724C (cg-RX-API-DMAC10.html)
FR (1) FR2464262A1 (cg-RX-API-DMAC10.html)
GB (1) GB2057437B (cg-RX-API-DMAC10.html)
GR (1) GR69849B (cg-RX-API-DMAC10.html)
IE (1) IE50231B1 (cg-RX-API-DMAC10.html)
IT (1) IT1193979B (cg-RX-API-DMAC10.html)
NL (1) NL183080C (cg-RX-API-DMAC10.html)
NO (1) NO156010C (cg-RX-API-DMAC10.html)
SE (1) SE448455B (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507314A (en) * 1983-07-20 1985-03-26 Midit, Societe Fiduciaire Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections
WO1987006128A1 (en) * 1986-04-07 1987-10-22 Clemetson Ab Charles Catechin coated ascorbic acid and method
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH0662408B2 (ja) * 1987-10-01 1994-08-17 太陽化学株式会社 抗う蝕及び抗歯周病組成物
JPH0672091B2 (ja) * 1988-04-13 1994-09-14 太陽化学株式会社 抗う蝕組成物
US5090785A (en) * 1990-07-31 1992-02-25 Stamp John R Multi-compartment container
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
GB2306321A (en) * 1995-10-24 1997-05-07 Anne Child The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders
GB9700912D0 (en) 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
AU6918700A (en) 1999-08-20 2001-03-19 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
US7252834B2 (en) 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
WO2006124033A2 (en) * 2005-05-17 2006-11-23 Mitsui Norin Co., Ltd Compositions and methods for reduction of cutaneous photoageing
US8496911B2 (en) 2009-07-29 2013-07-30 Vatrix CHF, Inc. Tissue stabilization for heart failure
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
EP2709711B8 (en) 2011-05-18 2017-03-22 Vatrix Medical, Inc. Coated balloons for blood vessel stabilization
BE1023772B9 (fr) * 2013-05-17 2017-08-02 Valore Composition a base d'un complexe de (+)-catechine et d'acide amine pour le traitement et la prevention du cancer
BE1022579A9 (fr) * 2014-11-10 2016-10-06 Valore Composition antimétastatique comprenant au moins un composé de type flavanol
TWI761672B (zh) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
US10617705B1 (en) 2019-01-24 2020-04-14 Alps Pharmaceutical Ind. Co., Ltd. Isoquercitrin compositions
US10918654B1 (en) 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270003A (en) * 1964-08-07 1966-08-30 Rayonier Inc Iron complexed sulfonated polyflavonoids and their preparation
FR2128207B1 (cg-RX-API-DMAC10.html) * 1971-03-11 1974-08-02 Zyma Sa
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01

Also Published As

Publication number Publication date
CH646412A5 (fr) 1984-11-30
DE3031710A1 (de) 1981-03-12
FR2464262B1 (cg-RX-API-DMAC10.html) 1983-07-08
DE3031710C2 (de) 1987-03-12
NL183080C (nl) 1988-07-18
JPS5923313B2 (ja) 1984-06-01
NL8004873A (nl) 1981-03-03
NO156010B (no) 1987-03-30
GB2057437A (en) 1981-04-01
NO156010C (no) 1987-07-08
US4285964A (en) 1981-08-25
IT8024310A0 (it) 1980-08-27
DK358980A (da) 1981-03-01
IE801823L (en) 1981-02-28
FI72724C (fi) 1987-07-10
FI72724B (fi) 1987-03-31
JPS5655386A (en) 1981-05-15
JPS59144779A (ja) 1984-08-18
GR69849B (cg-RX-API-DMAC10.html) 1982-07-19
DK153948B (da) 1988-09-26
FR2464262A1 (fr) 1981-03-06
ES494668A0 (es) 1981-08-16
SE8005890L (sv) 1981-03-01
ATA432080A (de) 1983-02-15
IT1193979B (it) 1988-08-31
SE448455B (sv) 1987-02-23
FI802652A7 (fi) 1981-03-01
NO802563L (no) 1981-03-02
DK153948C (da) 1989-02-13
CA1172259A (en) 1984-08-07
GB2057437B (en) 1984-08-30
BE884743A (fr) 1980-12-01
AT372381B (de) 1983-09-26
ES8106513A1 (es) 1981-08-16
JPS5946947B2 (ja) 1984-11-15

Similar Documents

Publication Publication Date Title
US4285964A (en) Salts of (+)-catechine, their preparation and use, and compositions containing these salts
CY1201A (en) Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
US20140080875A1 (en) 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof
US2835702A (en) Benzene 1, 3 disulfonamides possessing diuretic properties
US4073895A (en) Isopropylamino pyrimidine orthophosphate
DE69313640T2 (de) Zink-tranexamat derivat
DE3215610C2 (de) N-Acylthiazolidine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2881958C (en) Pharmaceutical formulations containing 3-(4-cinnamyl-1-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation
HU199289B (en) Process for production of liofilized medical compositions containing derivatives of phenil-quinoline-carbonic acid
DE2519059A1 (de) Neue aminoderivate von 6-phenylpyrazolo(3.4-b)pyridinen
US3658989A (en) Antibacterial composition containing tetracycline sulfamate and derivatives thereof
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
EP0022737B1 (fr) Imines dérivées de l'amino-5 benzodioxole-1,3 utiles comme médicaments et leur préparation
DE3215482C2 (de) Komplexe aus Natriumsalzen von 4-Hydroxy-cumarinen und Alkoholen und Verfahren zu deren Herstellung
DE1792270C3 (de) Antirheumatikum enthaltend ein Magnesium- oder Calciumsalz eines Malonsäurehydrazid s
KR830000525B1 (ko) 주사용 아세틸 살리실레이트 분말제의 안정화 방법
KR900006216B1 (ko) 탄닌산 카나마이신과 그 제조방법 및 그 용도와 의약조성물
KR19980035382A (ko) 신규한 비페닐 디카르복실산 유도체와 이의 제조방법
JPS62106094A (ja) エトド−ル酸ナトリウム及びその製造方法
DE2010010A1 (en) Bactericidal 6-aminopenicillanic acid deriva - fatty acids.
DE1593015B2 (de) N,n'-dimethyl-n,n'-di-(tetracyclinomethyl)-aethylendiamin und dessen salze mit pharmakologisch unbedenklichen mineral- und organischen saeuren sowie verfahren zu deren herstellung
JPS58162522A (ja) 火傷治療用薬剤
JPH01501387A (ja) ２―メチルメルカプト―３―シアノ―４―（０―ジフルオロメトキシフェニル）―６―フェニル―１，４―ジヒドロピリジン
DE4443167A1 (de) Salze der (R)-(-)-2-Cycloheptyl-2-/3-isobutyl-4-(chinolin-2-yl-methoxy)/phenylessigsäure